BAYER DIAGNOSTICS ACS:180 VB12, BAYER DIAGNOSTICS ADVIA CENTAUE VB12

Radioassay, Vitamin B12

BAYER CORP.

The following data is part of a premarket notification filed by Bayer Corp. with the FDA for Bayer Diagnostics Acs:180 Vb12, Bayer Diagnostics Advia Centaue Vb12.

Pre-market Notification Details

Device IDK993571
510k NumberK993571
Device Name:BAYER DIAGNOSTICS ACS:180 VB12, BAYER DIAGNOSTICS ADVIA CENTAUE VB12
ClassificationRadioassay, Vitamin B12
Applicant BAYER CORP. 63 NORTH ST. Medfield,  MA  02052 -1688
ContactThomas F Flynn
CorrespondentThomas F Flynn
BAYER CORP. 63 NORTH ST. Medfield,  MA  02052 -1688
Product CodeCDD  
CFR Regulation Number862.1810 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received1999-10-21
Decision Date1999-12-16
Summary:summary

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
00630414600314 K993571 000
00630414294100 K993571 000
00630414294261 K993571 000
00630414054124 K993571 000
00630414124780 K993571 000
00630414124919 K993571 000
00630414124926 K993571 000
00630414175300 K993571 000
00630414177168 K993571 000
00630414177175 K993571 000
00630414204758 K993571 000
00630414443010 K993571 000
00630414598338 K993571 000
00630414598345 K993571 000
00630414600277 K993571 000
00630414600284 K993571 000
00630414600291 K993571 000
00630414600307 K993571 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.